CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $711,000 | -82.8% | 27,177 | -88.6% | 0.00% | -88.9% |
| Q3 2020 | $4,144,000 | +196.4% | 237,990 | +102.3% | 0.03% | +145.5% |
| Q1 2020 | $1,398,000 | +544.2% | 117,644 | +554.3% | 0.01% | +1000.0% |
| Q4 2019 | $217,000 | -76.1% | 17,980 | -77.9% | 0.00% | -83.3% |
| Q2 2019 | $907,000 | -70.1% | 81,348 | -68.5% | 0.01% | -45.5% |
| Q1 2019 | $3,032,000 | +54.9% | 258,270 | +76.4% | 0.01% | -42.1% |
| Q4 2018 | $1,957,000 | +91.5% | 146,423 | +125.2% | 0.02% | +216.7% |
| Q2 2018 | $1,022,000 | -80.7% | 65,012 | -79.8% | 0.01% | -76.9% |
| Q1 2018 | $5,285,000 | -40.4% | 321,264 | -31.1% | 0.03% | -53.6% |
| Q3 2017 | $8,863,000 | -36.4% | 466,460 | -59.9% | 0.06% | -45.1% |
| Q2 2017 | $13,942,000 | – | 1,161,830 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |